CLINICAL_TRIALS
research
· 2014-12-11
Clinical Trial Update: Rosuvastatin in Order to Induce Preeclampsia Resolution in Severe PET up to 48 Hours Following Delivery [Phase 1, Phase 2]
Summary
A Phase 1/2 clinical trial exploring rosuvastatin to induce resolution of severe preeclampsia up to 48 hours after delivery.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Soroka University Medical Center | Conditions: Severe Pre-eclampsia | Phase 1, Phase 2 | Status: UNKNOWN